EU MDR Biocompatibility Support for Medical Devices
Preparing EU MDR technical documentation, assessing a device change or answering a notified body question? Start with a scoped evidence review and a written list of gaps and next documentation steps.
Clarify what your EU MDR biological-evaluation evidence supports and what needs attention
MedDev Advisory provides independent ISO 10993 evidence and documentation support. An initial non-confidential fit check is free; document review and drafting are paid work with scope, deliverables and timing agreed in writing. This does not include laboratory testing, complete conformity-assessment execution or manufacturer and authorised-representative responsibilities, and does not imply CE marking or notified-body acceptance.
Initial EU MDR Technical Documentation
You need a device-specific Annex I, Chapter II, point 10 narrative linked to the biological-evaluation evidence in your technical documentation.
Notified Body Query
Where applicable, the reviewer flagged weak biological-evaluation justification, unsupported endpoint rationales, missing material framing or poor alignment with Annex I requirements.
Legacy Documentation Upgrade
Your older biological-evaluation records need review for evidence gaps, lifecycle changes, benefit-risk reasoning and the standards relevant to the current device.
Need Better Technical-Documentation Integration
You have reports, but they are not clearly tied to risk management, material composition and the wider EU MDR technical documentation.
What a focused EU MDR evidence review could produce
A manufacturer is updating EU MDR technical documentation after a supplier or process change. It has earlier biological-evaluation records, current finished-device information and a notified-body question.
1. Confirm the current device-to-evidence scope
Review question: Do the existing records represent the current materials, manufacturing, sterilisation and final finished configuration?
Possible output: Device-to-evidence comparison and missing-input list.
2. Map evidence to the relevant EU MDR questions
Review question: Which endpoint conclusions, chemistry or TRA records and risk controls support the applicable Annex I point 10 questions, and where are gaps or assumptions?
Possible output: Traceable evidence map with unresolved questions and actions.
3. Create the reviewer-facing route
Review question: What needs to change in the GSPR 10 narrative or point-by-point response so the reasoning and evidence limits are clear?
Possible output: Prioritised action register and scoped narrative or response structure.
This fictional example does not establish evidence applicability, device equivalence, an endpoint waiver, CE marking or notified-body acceptance. Exact outputs depend on the agreed scope and available inputs.
Common reasons EU MDR biocompatibility sections attract notified-body questions
These recurring gaps can make technical documentation harder to review. Resolving them early clarifies what the evidence supports and what still needs action.
Current-Device Representation Is Unclear
Earlier tests or biological-evaluation records may not represent the current materials, supplier, manufacturing, sterilisation or final finished configuration.
Evidence Is Not Traceable Into the Technical Documentation
BEP, BER or equivalent records may exist, but their conclusions are not clearly linked to Annex I point 10, risk management and the submitted device configuration.
Endpoint or Existing-Evidence Rationale Is Weak
Each endpoint conclusion needs a traceable scientific rationale. Literature, chemistry, TRA and earlier test reports need an explicit connection to the current device and review question.
Lifecycle, Change and GSPR Reasoning Is Incomplete
A generic narrative may omit device changes, remaining biological risks, benefit-risk reasoning or evidence limitations even when useful supporting records exist.
Read the guidance that matches your immediate problem
How EU MDR biocompatibility support is typically structured
The work is scoped around the actual device, current evidence package and whether the goal is an EU MDR technical-documentation section, a change assessment or a response to reviewer comments.
Free Initial Fit Check
Share a non-confidential device brief and the question you need to resolve. Paid review starts only after scope, deliverables, fee and timing are agreed.
Map the Biological Evidence Story
Review BEP, BER or equivalent records, TRA, tests, literature and risk-management evidence to show what each conclusion relies on and where evidence or reasoning is missing.
Draft the Reviewer-Facing Section
Draft the agreed GSPR 10 narrative or response structure, linking conclusions to supporting records and making unresolved evidence needs explicit.
Finalize or Remediate
Refine the agreed deliverable with your team and distinguish addressed questions from evidence gaps that still need action.
Questions teams usually ask before starting
What do you need from us to begin?
For the free fit check, share a non-confidential device description, intended use, contact profile, target EU MDR question and deadline. Supporting files are requested later through an agreed channel.
Can you help after the notified body has already commented?
Yes. MedDev Advisory can scope a point-by-point response to the biological-evaluation questions raised, using your existing documentation and identifying where supporting evidence or reasoning is missing.
Do you only work on standalone BERs?
No. The value is often in technical-documentation integration: linking biological-evaluation logic to Annex I wording, material framing, risk management and the current device configuration.
Is this relevant if our BER is older?
Yes. The review can identify evidence gaps and improve links between documents. MedDev Advisory checks which standards and market requirements are relevant before recommending updates; the publication of a newer edition alone does not establish its regulatory status.
Need a stronger EU MDR biocompatibility section?
Send a non-confidential device brief and the question or deadline you need to address. The initial fit check is free; any evidence review, drafting or response work is scoped and agreed separately.